Floatz logo

Abi-009

Epilepsy Intractable

Seattle Children's HospitalPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Epilepsy Intractable cohort.

Asset / SponsorPhaseRating
plt101
PhytoTech Therapeutics, Ltd.
Phase 2B
Clioquinol
KU Leuven
Phase 2CCC
Npt 2042
NeuroPro Therapeutics, Inc.
Phase 1CCC
Ciprofloxacin
Mazandaran University of Medical Sciences
N/AD

Same molecule, other indications

Abi-009 is also rated in:

Leigh syndromeDormant
CCC
Indicative ·
53 / 100
View asset →
neoplasmDormant
CC
Indicative ·
40 / 100
View asset →
plasma cell myelomaDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →